SG11202005359TA - Phenoxy acids for the treatment of neuromuscular disorders - Google Patents
Phenoxy acids for the treatment of neuromuscular disordersInfo
- Publication number
- SG11202005359TA SG11202005359TA SG11202005359TA SG11202005359TA SG11202005359TA SG 11202005359T A SG11202005359T A SG 11202005359TA SG 11202005359T A SG11202005359T A SG 11202005359TA SG 11202005359T A SG11202005359T A SG 11202005359TA SG 11202005359T A SG11202005359T A SG 11202005359TA
- Authority
- SG
- Singapore
- Prior art keywords
- treatment
- neuromuscular disorders
- phenoxy acids
- phenoxy
- acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/12—Acetic acid esters
- C07C69/14—Acetic acid esters of monohydroxylic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
- C07C69/736—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762598940P | 2017-12-14 | 2017-12-14 | |
EP18151605 | 2018-01-15 | ||
PCT/EP2018/084980 WO2019115777A1 (en) | 2017-12-14 | 2018-12-14 | Phenoxy acids for the treatment of neuromuscular disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202005359TA true SG11202005359TA (en) | 2020-07-29 |
Family
ID=64661403
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202005359TA SG11202005359TA (en) | 2017-12-14 | 2018-12-14 | Phenoxy acids for the treatment of neuromuscular disorders |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP3723745A1 (es) |
JP (1) | JP2021506813A (es) |
KR (1) | KR20200099146A (es) |
CN (1) | CN111587109A (es) |
AU (1) | AU2018382597B2 (es) |
CA (1) | CA3085226A1 (es) |
IL (1) | IL274744B2 (es) |
MX (1) | MX2020005398A (es) |
SG (1) | SG11202005359TA (es) |
TW (1) | TWI794369B (es) |
WO (1) | WO2019115777A1 (es) |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1586463A (en) | 1976-08-02 | 1981-03-18 | Shell Int Research | Herbicidal compositions |
KR100552133B1 (ko) | 2002-06-26 | 2006-02-14 | 한국화학연구원 | 광학활성 (r)-아릴옥시 프로피온산 에스터 유도체의제조방법 |
SE0301009D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
GB0409921D0 (en) | 2004-05-04 | 2004-06-09 | Novartis Ag | Organic compounds |
GB0422057D0 (en) | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
US7989469B2 (en) * | 2008-02-04 | 2011-08-02 | Cytokinetics, Incorporated | Certain chemical entities, compositions, and methods |
US8999974B2 (en) | 2010-08-09 | 2015-04-07 | Raqualia Pharma Inc. | Acyl piperazine derivatives as TTX-S blockers |
CA2986611C (en) * | 2015-06-15 | 2023-10-03 | Nmd Pharma Aps | Compounds for use in treating neuromuscular disorders |
US10869858B2 (en) * | 2015-10-29 | 2020-12-22 | Tohoku University | Therapeutic agent for amyotrophic disorders |
-
2018
- 2018-12-13 TW TW107145015A patent/TWI794369B/zh active
- 2018-12-14 AU AU2018382597A patent/AU2018382597B2/en active Active
- 2018-12-14 CA CA3085226A patent/CA3085226A1/en active Pending
- 2018-12-14 SG SG11202005359TA patent/SG11202005359TA/en unknown
- 2018-12-14 CN CN201880080205.1A patent/CN111587109A/zh active Pending
- 2018-12-14 JP JP2020532801A patent/JP2021506813A/ja active Pending
- 2018-12-14 WO PCT/EP2018/084980 patent/WO2019115777A1/en unknown
- 2018-12-14 MX MX2020005398A patent/MX2020005398A/es unknown
- 2018-12-14 EP EP18815729.1A patent/EP3723745A1/en active Pending
- 2018-12-14 KR KR1020207017872A patent/KR20200099146A/ko not_active Application Discontinuation
-
2020
- 2020-05-18 IL IL274744A patent/IL274744B2/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3723745A1 (en) | 2020-10-21 |
JP2021506813A (ja) | 2021-02-22 |
CN111587109A (zh) | 2020-08-25 |
CA3085226A1 (en) | 2019-06-20 |
AU2018382597A1 (en) | 2020-07-02 |
TWI794369B (zh) | 2023-03-01 |
AU2018382597B2 (en) | 2024-04-04 |
IL274744A (en) | 2020-07-30 |
IL274744B2 (en) | 2023-02-01 |
IL274744B (en) | 2022-10-01 |
KR20200099146A (ko) | 2020-08-21 |
WO2019115777A1 (en) | 2019-06-20 |
MX2020005398A (es) | 2020-08-17 |
TW201938525A (zh) | 2019-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL271085A (en) | Bacteria to treat disorders | |
IL270752B (en) | Pyrrolopyridine-aniline compounds for the treatment of skin disorders | |
HK1256721A1 (zh) | 用於治療眼部病症的化合物和組合物 | |
HUE056356T2 (hu) | Tetrahidro-8H-pirido[1,2-a]pirazin-8-on vegyületek, mint COMT inhibitorok neurodegeneratív rendellenességek kezelésére | |
ZA202002993B (en) | Compounds for the treatment of neuromuscular disorders | |
IL267818A (en) | Methods for treating neurological disorders | |
EP3606598A4 (en) | METHOD OF NEURAL INTERVENTION FOR TREATMENT OF AFFECTIVE NEUROPSYCHIATRIC DISORDERS | |
GB201612165D0 (en) | Combinations for the treatment of type 2 diabetes | |
EP3119387A4 (en) | Compositions for the treatment of dermatological diseases and disorders | |
IL288234A (en) | Compounds for the treatment of neuromuscular disorders | |
DK3723746T3 (da) | Phenoxysyrer til behandling af neuromuskulære lidelser | |
IL274744B (en) | Phenoxy acids for the treatment of neuromuscular disorders | |
IL269681A (en) | New methods for treating multiple sclerosis | |
HK1250624A1 (zh) | 用於治療心血管障礙的方法 | |
PT3724173T (pt) | Compostos para o tratamento de distúrbios neuromusculares | |
HRP20181123T1 (hr) | Spojevi 3,4-diamino-6-kloropirazin-2-karboksamida za liječenje bolesti posredovanih s enac | |
IL254140A0 (en) | Preparations and combinations for use in the treatment of angiogenic diseases and disorders | |
AU2016905227A0 (en) | Treatment of iron disorders | |
GB201521542D0 (en) | Methods for the treatment of cardiovascular disorders | |
EP3247396A4 (en) | Methods and compositions for the treatment of diseases and disorders | |
GB201517995D0 (en) | Products for treating psychogenic pain disorders | |
GB201513991D0 (en) | Methods for the treatment of cardiovascular disorders | |
GB201513344D0 (en) | Methods for the treatment of Cardiovascular disorders | |
GB201507109D0 (en) | Methods for the treatment of cardiovascular disorders | |
AU2014902257A0 (en) | Treatment of immune disorders 2 |